Gastroenterology

New AI platform detects neurodegenerative diseases in brain tissue samples




Researchers have developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer’s disease and chronic traumatic encephalopathy, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published in the Nature medical journal Laboratory Investigation.

Source link




Related posts

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Newsemia

Micronutrient Deficiencies Often Found With Celiac Disease Dx

Newsemia

‘Quest for better HDV therapy’: triple combination reduces RNA in most

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy